Clinical Trial Update: A Clinical Trial Evaluating the Safety and Efficacy of Intravenous HNF4α SrRNA in Treating Metastatic CRC Patients [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 clinical trial is evaluating intravenous HNF4α siRNA for safety and efficacy in patients with metastatic colorectal cancer and is currently rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• HNF4α siRNA (HNF4A siRNA)

Snippet

Sponsor: Shanghai Changzheng Hospital | Conditions: Metastatic Colorectal Cancer (mCRC) | EARLY_Phase 1 | Status: RECRUITING